TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
ANAB

AnaptysBio Inc

Healthcare · Biotechnology

55.10$ +1.4% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Cash Flow

AnaptysBio Inc (ANAB) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at 20 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow ANAB
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
15 -9.7 -9.0 -19 -49 -70 -14 -46 -74 -121 -135 20
0.3 0.3 0.2 0.2 0.3 0.5 0.6 2.1 2.3 2.4 2.4 2.4
0.2 0.6 1.2 4.4 10.0 12 11 15 27 33 34 36
1.5 2.0 2.0 6.4 -0.6 0.7 12 1.9 19
9.3 -6.5 -7.0 4.1 3.5 17 -6.8 -7.5 6.8 -0.3 -66 -81
0.1 0.2 0.1 0.3 1.1 0.8 0.6 1.4 0.4 0.8 0.4 0.1
-0.1 -0.2 -0.1 -243 -142 131 94 39 -395 145 95 228
0.0 12
0.2 41 0.0 294 230 3.0 0.5 2.6 12 -50 -0.5 -69
5.0 10 10 -6.9 -6.9 -7.5 -1.4 0.0 0.0
4.9 39 8.6 292 223 -4.5 -0.9 252 44 -59 127 -133
19 29 -0.5 30 32 57 79 245 -424 -35 87 115
14 -9.9 -9.1 -20 -50 -70 -15 -47 -74 -122 -136 20

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?